Mark Alan Goldberg - 31 Mar 2023 Form 4 Insider Report for ImmunoGen, Inc.

Role
Director
Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 Mar 2023
Net transactions value
+$16,873
Form type
4
Filing time
04 Apr 2023, 16:51:14 UTC
Previous filing
04 Jan 2023
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $16,873 +4,394 +8.2% $3.84* 58,194 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock issued pursuant to the Compensation Policy for Non-Employee Directors as amended December 15, 2022 for services performed for the quarter ended March 31, 2023.